首頁 > 市場調查報告書 > 製藥

藥物開發以基因為基之藥物開發生物標記

市場調查報告書

商品編碼

1741541

患者來源異種移植模型市場（按模型類型、移植方法、腫瘤類型、最終用戶和地區分類）

Patient Derived Xenograft Model Market, By Model Type, By Implantation Method, By Tumor Type, By Application, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

患者來源異種移植模型市場規模預計在 2025 年達到 1.474 億美元，預計到 2032 年將達到 4.836 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 18.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	1.474億美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年年複合成長率：	18.50%	2032年價值預測	4.836億美元

患者來源異種移植 (PDX) 模型是腫瘤學研究中使用的尖端臨床前研究工具。在這種腫瘤模型中，癌症患者的腫瘤組織被移植到小鼠等免疫力缺乏的動物體內，以更真實地模擬人類腫瘤的行為。 PDX 模型因其能夠模擬患者特異性腫瘤特徵和治療反應，在藥物研發中廣受歡迎。

此理論資訊部落格旨在概述患者來源的異種移植模型市場，包括其市場動態和主要特徵，這將有助於相關人員了解該市場的當前和未來趨勢並做出明智的決策。

市場動態：

預計未來幾年，患者來源的異種移植模型市場將顯著成長。推動這一市場擴張的因素有很多。首先，全球癌症發生率的上升催生了對有效治療方案的強烈需求。 PDX 模型是研究腫瘤生物學、評估藥物療效和確定個人化治療策略的寶貴工具。

此外，精準醫療和個人化治療日益受到關注，也推動了PDX模型市場的成長。這些模型提供了一個平台，用於測試新型候選藥物並評估特定患者群體的潛在反應。此外，製藥和生物技術公司擴大採用PDX模型進行臨床前試驗，也推動了市場的成長。

然而，患者來源異種移植模型市場也面臨許多挑戰。主要阻礙因素之一是建立和維護PDX模型的高成本。這些模型的複雜性，包括遺傳異質性以及對專業基礎設施和專業知識的需求，進一步增加了整體成本。

儘管如此，該市場仍為主要企業提供了許多誘人的機會。基因組編輯工具和人源化小鼠模型等技術進步將提升PDX模型的效用和可移植性。此外，製藥公司、學術機構和受託研究機構之間的合作可能會進一步加速PDX模型的普及和普及。

本研究的主要特點

這項關於患者來源異種移植模型市場的研究涵蓋了各種關鍵特徵，為市場格局提供了全面的見解，包括：

市場規模與成長：提供全球病患來源異種移植模型市場的詳細分析，包括預測期 2025-2032 的市場規模（百萬美國）和年複合成長率（CAGR%），假設 2024 年為基準年。
商機：它揭示了各個細分市場中的潛在商機，並提出了一系列有吸引力的投資提案，以幫助相關人員識別有利可圖的機會。
市場促進因素、限制因素和機會：它提供了對市場促進因素、限制因素和機會的關鍵見解，闡明了影響機會成長的因素，並強調了新產品的發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略。
公司簡介：根據公司亮點、產品系列、主要成就、財務表現、策略等參數，概述全球患者來源異種移植模型市場的主要企業。研究涵蓋的公司名單包括傑克遜實驗室、Champions Oncology、Charles River Laboratories、Crown Bioscience、EPO Berlin-Buch、Explora BioLabs、Hera Biolabs、Horizon Discovery Group、Oncodesign、Pharmatest Services、上海立德生物科技、Xentech、Aragen Biosciencesciencescience、Bioduro、Pharmatest Services、HirgenCdelal、Xentech、Aragen Biosciencescience、Bioduro、Cdelal、Coled、Cdelal、Xentech） Performance、無錫藥明康德和安進。
決策洞察該報告為負責人和經營團隊提供了寶貴的洞察，以便就產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
相關人員的利益：全球患者來源的異種移植模型市場報告針對行業中的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者、財務分析師等，以透過用於市場分析的各種策略矩陣促進決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 147.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	18.50%	2032 Value Projection:	USD 483.6 Mn

Patient Derived Xenograft (PDX) Model is a cutting-edge preclinical research tool used in oncology research. It is a type of tumor model where tumor tissues from cancer patients are implanted into mice or other immunodeficient animals to create a more realistic representation of the tumor's behavior in humans. PDX models have gained significant popularity in drug discovery and development due to their ability to mimic patient-specific tumor characteristics and response to treatments.

This theoretical informative blog aims to provide an overview of the Patient Derived Xenograft Model market, including its market dynamics and key features. It will assist stakeholders in understanding the current and future trends in this market and making informed decisions.

Market Dynamics:

The Patient Derived Xenograft Model market is expected to witness substantial growth in the coming years. Several factors are driving this market expansion. Firstly, the increasing prevalence of cancer globally is creating a strong demand for effective treatment options. PDX models offer a valuable tool for studying tumor biology, evaluating drug efficacy, and identifying personalized treatment strategies.

Moreover, the rising focus on precision medicine and personalized therapies further contributes to the growth of the PDX model market. These models provide a platform for testing novel drug candidates and evaluating their potential response in specific patient cohorts. Additionally, the growing adoption of PDX models by pharmaceutical and biotechnology companies for preclinical testing is boosting market growth.

However, the Patient Derived Xenograft Model market also faces some challenges. One of the key restraints is the high cost associated with creating and maintaining PDX models. The complexity of these models, including genetic heterogeneity and the need for specialized infrastructure and expertise, adds to the overall expenses.

Nevertheless, the market presents several attractive opportunities for key players. Advancements in technology, such as genome editing tools and humanized mouse models, enhance the utility and translatability of PDX models. Moreover, collaborations between pharmaceutical companies, academic research institutions, and contract research organizations are likely to further accelerate the adoption and availability of PDX models.

Key Features of the Study:

This study on the Patient Derived Xenograft Model market encompasses various essential features, providing comprehensive insights into the market landscape:

Market Size and Growth: The report offers an in-depth analysis of the global Patient Derived Xenograft Model market, including market size (in US$ Million) and compound annual growth rate (CAGR%) for the forecast period of 2025-2032, with 2024 as the base year.
Revenue Opportunities: It elucidates potential revenue opportunities across different market segments and presents attractive investment proposition matrices, aiding stakeholders in identifying lucrative opportunities.
Market Drivers, Restraints, and Opportunities: The study provides key insights into market drivers, restraints, and opportunities, shedding light on factors influencing market growth. It also highlights new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
Company Profiles: Key players in the global Patient Derived Xenograft Model market are profiled based on parameters such as company highlights, product portfolio, key achievements, financial performance, and strategies. The list of companies covered in this study includes The Jackson Laboratory, Champions Oncology, Charles River Laboratories, Crown Bioscience, EPO Berlin-Buch, Explora BioLabs, Hera Biolabs, Horizon Discovery Group, Oncodesign, Pharmatest Services, Shanghai LIDE Biotech, Xentech, Aragen Bioscience, Bioduro, Creative Animodel, Urolead, Applied StemCell, Biomodel Performance, WuXi AppTec, and Amgen.
Decision-Making Insights: The report equips marketers and management authorities with valuable insights to make informed decisions regarding product launches, type up-gradation, market expansion, and marketing tactics.
Stakeholder Benefits: The global Patient Derived Xenograft Model market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts. It provides ease in decision-making through various strategy matrices utilized in analyzing the market.

Patient Derived Xenograft Model Market Segmentation:

By Model Type
- Mice Models
- Rat Models
- Humanized Models
- Direct Patient Derived Xenograft Models
- Other Models
By Tumor Type
- Blood Cancer Models
- Solid Tumor Models
- Pediatric Tumor Models
- Other Rare Tumor Models
- Combination PDX Models
- Custom PDX Models
- Others
By Application
- Preclinical Drug Development
- Biomarker Analysis
- Personalized Medicine
- Co-Clinical Trials
- Other Research Applications
- Therapeutic Applications
By End User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic & Research Institutions
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- The Jackson Laboratory
- Champions Oncology
- Charles River Laboratories
- Crown Bioscience
- EPO Berlin-Buch
- Explora BioLabs
- Hera Biolabs
- Horizon Discovery Group
- Oncodesign
- Pharmatest Services
- Shanghai LIDE Biotech
- Xentech
- Aragen Bioscience
- Bioduro
- Creative Animodel
- Urolead
- Applied StemCell
- Biomodel Performance
- WuXi AppTec
- Amgen

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Patient Derived Xenograft Model, By Model Type
- Market Patient Derived Xenograft Model, By Implantation Method
- Market Patient Derived Xenograft Model, By Tumor Type
- Market Patient Derived Xenograft Model, By End User
- Market Patient Derived Xenograft Model, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Cancer Research
- Restraints
Limitations of PDX Models
- Opportunities
Applications in Immunotherapy Testing
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Patient Derived Xenograft Model Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Patient Derived Xenograft Model Market, By Model Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Tumor explant models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cell line derived models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Patient derived organoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Genetically engineered models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others (Primary cell derived models, cell processed models etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Patient Derived Xenograft Model Market, By Model Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Subcutaneous Implantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Orthopedic Implantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Patient Derived Xenograft Model Market, By Tumor Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
Gastrointestinal Tumor Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Gynecological Tumor Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Respiratory Tumor Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Other Tumor Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Patient Derived Xenograft Model Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Academic & Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

9. Patient Derived Xenograft Model Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

THE JACKSON LABORATORY
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Champions Oncology, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Crown Bioscience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hera Biolabs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Horizon Discovery Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Oncodesign
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pharmatest Services
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Shanghai LIDE Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aragen Life Sciences Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Creative Animodel
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Urosphere
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Applied StemCell
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

病患來源異質骨移植/PDX 模型市場分析及預測（至 2034 年）：類型、產品、服務、技術、應用、最終使用者、階段、組件、流程

患者來源異質骨移植/PDX 模型市場（按類型、腫瘤類型、研究類型、植入方法、應用和最終用戶分類）—2025 年至 2030 年全球預測

全球患者來源異種移植模型市場規模（按癌症類型、組織來源、應用、地區、範圍和預測）

異種移植市場，按產品、按應用、按最終用戶、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

患者衍生異種移植 (PDX) 模型市場，按腫瘤類型、模型、最終用戶、國家和地區分類 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

異種移植市場規模 - 按產品類型（器官保存解決方案、移植診斷、異種產品）、按應用（腎、心、肝、肺）、按最終用途 - 到2032年的全球預測

FAQ

患者來源異種移植模型市場（按模型類型、移植方法、腫瘤類型、最終用戶和地區分類）